Per2-Mediated Vascular Dysfunction Is Caused by the Upregulation of the Connective Tissue Growth Factor (CTGF).
Period 2-mutant mice (Per2m/m), which possess a circadian dysfunction, recapitulate the retinal vascular phenotype similar to diabetic retinopathy (DR). The vascular dysfunction in Per2m/m is associated with an increase in connective tissue growth factor (CTGF/CCN2). At the molecular level, CTGF gene expression is dependent on the canonical Wnt/β-catenin pathway. The nuclear binding of β-catenin to a transcription factor, lymphoid enhancer binding protein (Lef)/ T-cell factor (TCF/LEF), leads to downstream activation of CTGF. For this study, we hypothesized that the silencing of Per2 results in nuclear translocation and subsequent transactivation of the CTGF gene. To test this hypothesis, we performed immunofluorescence labeling for CTGF in retinal sections from wild-type (WT) and Per2m/m mice. Human retinal endothelial cells (HRECs) were transfected with siRNA for Per2, and the protein expression of CTGF and β-catenin was evaluated. The TCF/LEF luciferase reporter (TOPflash) assay was performed to validate the involvement of β-catenin in the activation of CTGF. Per2m/m retinas exhibited an increased CTGF immunostaining in ganglion cell layer and retinal endothelium. Silencing of Per2 using siRNA resulted in an upregulation of CTGF and β-catenin. The TOPflash assay revealed an increase in luminescence for HRECs transfected with Per2 siRNA. Our studies show that loss of Per2 results in an activation of CTGF via nuclear entry of β-catenin. Our study provides novel insight into the understanding of microvascular dysfunction in Per2m/m mice.
Department of Ophthalmology, Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
Vaishnavi
V
Jadhav
Department of Ophthalmology, Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
Qianyi
Q
Luo
Department of Ophthalmology, Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
James
J
M Dominguez
Department of Ophthalmology, Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
Jude
J
Al-Sabah
Department of Cell Biology, Suny Downstate Medical Center, Brooklyn, New York, United States of America.
Brahim
B
Chaqour
Department of Ophthalmology, Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
Maria B
MB
Grant
Department of Ophthalmology, Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
Ashay D
AD
Bhatwadekar
Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):15043-8
19706469
Neuron. 2001 May;30(2):525-36
11395012
Nature. 2005 Mar 31;434(7033):640-4
15800623
Nature. 2002 Aug 29;418(6901):935-41
12198538
PLoS One. 2008 Jul 16;3(7):e2675
18628999
PLoS One. 2013 Jun 27;8(6):e67265
23826252
Circulation. 2011 Oct 25;124(17):1871-81
21969016
Eur J Neurosci. 2013 Apr;37(7):1048-60
23351077
Neurobiol Dis. 2002 Jun;10(1):33-40
12079402
Science. 2001 Feb 9;291(5506):1040-3
11232563
Continuum (Minneap Minn). 2013 Feb;19(1 Sleep Disorders):132-47
23385698
Brain Res. 2000 Jul 7;870(1-2):118-25
10869508
Brain Res Mol Brain Res. 1999 Sep 8;72(1):108-14
10521605
Circulation. 2007 Apr 24;115(16):2188-95
17404161
Exp Eye Res. 2009 Jun;88(6):1076-83
19450451
Dev Cell. 2009 Jul;17(1):9-26
19619488
Diabetes Care. 2003 Jan;26 Suppl 1:S99-S102
12502630
Bioessays. 2008 Jul;30(7):624-33
18536031
Mol Cancer Res. 2008 Nov;6(11):1786-93
19010825
Circulation. 2008 Nov 18;118(21):2166-73
18981300
Cytokine Growth Factor Rev. 2008 Apr;19(2):133-44
18358427
Nature. 1999 Jul 8;400(6740):169-73
10408444
Invest Ophthalmol Vis Sci. 1998 Nov;39(12):2450-7
9804153
Curr Opin Rheumatol. 2002 Nov;14(6):681-5
12410091
Cell. 2004 Mar 19;116(6):883-95
15035989
Brain Res. 2001 Sep 7;912(2):195-202
11532436
Science. 1996 Apr 19;272(5260):419-21
8602533
Endocrinology. 2004 Feb;145(2):860-6
14592956
Diabetes. 2013 Jan;62(1):273-82
23193187
Graefes Arch Clin Exp Ophthalmol. 1998 Jan;236(1):41-6
9457515
J Exp Med. 2009 Dec 21;206(13):2897-906
19934019
Nat Med. 2005 Jan;11(1):35-42
15608650
PLoS Biol. 2008 Oct 14;6(10):e249
18959477
Diabetes. 2010 Jul;59(7):1809-16
20299474
Prog Retin Eye Res. 2014 Mar;39:58-76
24333669